A. Reinacher-Schick

Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy

Valentin Goede, Oliver Coutelle, Janina Neuneier et al. · British Journal of Cancer · 2010 · 186 citations · Full text

Medicine, Oncology, Pharmacology +17

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

Jan Harder, Gabriele Ihorst, Volker Heinemann et al. · British Journal of Cancer · 2012 · 184 citations · Full text

Medicine, Oncology, Pharmacology +17

Mesalazine Changes Apoptosis and Proliferation in Normal Mucosa of Patients with Sporadic Polyps of the Large Bowel

A. Reinacher-Schick, F. Seidensticker, S. Petrasch et al. · Endoscopy · 2000 · 93 citations

Medicine, Pharmacology, Pharmacotherapy +17

Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group

Wolff Schmiegel, A. Reinacher-Schick, Dirk Arnold et al. · Annals of Oncology · 2013 · 73 citations

Medicine, Oncology, Pharmacology +13

R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial

Rainer Fietkau, Robert Grützmann, Uwe A. Wittel et al. · Strahlentherapie und Onkologie · 2020 · 60 citations · Full text

Medicine, Oncology, Surgery +15